Digoxin Antibody Prevents Cerebral Hemorrhage-Induced Hypertension

American Journal of Hypertension

Volumn 16, Issue 12, 2003, Pages 1062-1065

  Menezes, João C ^a   Dichtchekenian, Varujan ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cerebral hemorrhage; Digoxin antibody; Hypertension; Ouabain like compound; Rat

Indexed keywords

DIGITALIS LIKE FACTOR; DIGOXIN ANTIBODY; DIGOXIN ANTIBODY F(AB) FRAGMENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; BRAIN HEMORRHAGE; BRAIN INJURY; CEREBROSPINAL FLUID; CONTROLLED STUDY; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SODIUM BALANCE;

EID: 0344196942     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2003.08.001     Document Type: Article

References (15)

1. Donnan GA, Davis SM, Thrift A: The role of blood pressure lowering before and after stroke. Curr Opin Neurol 2003;16:81-86.
2. Labovitz DL, Sacco RL: Intracerebral hemorrhage: update. Curr Opin Neurol 2001;14:103-108.
3. Perry HM Jr, Davis BR, Price TR, Applegate WB, Fields WS, Guralnik JM, Kuller I, Pressel S, Stamler J, Probstfield JL: Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke: the Systolic Hypertension in the Elderly Program (SHEP). JAMA 2000;284:465-471.
4. PROGRESS Collaborative Group: Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001; 358:1033-1041.
5. Loyke HF: The three phases of blood pressure in stroke. South Med J 1990;83:660-663.
6. Huang BS, Leenen FHH: Brain ouabain-like activity and the sympathoexitatory and pressor effects of central sodium in rats. Circ Res 1992;71:1059-1066.
7. Huang BS, Leenen FHH: Brain renin-angiotensin system and ouabain-induced sympathetic hyperactivity and hypertension in Wistar rats. Hypertension 1999;34:107-112.
8. de Wardener HE, Mills IH, Clapham WF, Hayter CJ: Studies on the efferent mechanism of the sodium diuresis which follows the administration of intravenous saline in the dog. Clin Sci 1961;21:249-258.
9. Blaustein MP, Juhaszova M, Golovina VA: The cellular mechanism of action of cardiotonic steroids: a new hypothesis. Clin Exp Hypertens 1998;20:691-703.
10. Wijdicks EFM, Vermeulen M, van Brummelen P: Digoxin-like immunoreactive substance in patients with aneurysmal subarachnoid hemorrhage. Br Med J 1987;294:729-732.
11. Yamada K, Goto A, Nagoshi H, Hui C, Omata M: Role of brain ouabain like compound in central nervous system-mediated natriuresis in rats. Hypertension 1994;23:1027-1031.
12. Dichtchekenian V, Gisiger S, Quental I, Santos SR, Marcondes M, Heimann JC: Higher salt consumption, digoxin-like factor, and nifedipine response are associated with salt sensitivity in essential hypertension. Am J Hypertens 1992;5:707-712.
13. Boucher BA, Lalonde RL: Digoxin-specific antibody fragments for the treatment of digoxin intoxication. Clin Pharm 1986;5: 826-827.
14. Woolfson RG, Poston L, de Wardener HE: Dioxin-like inhibitors of active sodium transport and blood pressure: the current status. Kidney Int 1994;46:297-309.
15. Verlooy J, van Reempts J, Haseldonckx M, Borgers M, Selosse P: Hemodynamic, intracranial pressure and electrocardiographic changes following subarachnoid hemorrhage in rats. Acta Neurochir 1992;115: 118-122.